Alibaba
BABA
Adobe
ADBE
Qualcomm
QCOM
4
Netflix
NFLX
5
Salesforce
CRM
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.2224
- -0.0034-1.51%
Close May 6 16:00 ET
- 0.2345
- +0.0121+5.44%
Pre 05:19 ET
9.29MMarket Cap-0.15P/E (TTM)
0.2440High0.2200Low538.78KVolume0.2200Open0.2258Pre Close127.41KTurnover1.73%Turnover RatioLossP/E (Static)41.79MShares1.900052wk High-0.33P/B6.93MFloat Cap0.160152wk Low--Dividend TTM31.15MShs Float51.3573Historical High--Div YieldTTM10.63%Amplitude0.1601Historical Low0.2360Avg Price1Lot Size
Carisma Therapeutics News
Carisma Therapeutics | 10-K/A: Annual report (Amendment)
CARISMA THERAPEUTICS Earnings Preview: Recent $CARM Insider Trading, Hedge Fund Activity, and More
Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations
The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 43%
BTIG Initiates Carisma Therapeutics(CARM.US) With Hold Rating
D. Boral Capital Initiates Carisma Therapeutics(CARM.US) With Buy Rating, Announces Target Price $1
12 Health Care Stocks Moving In Tuesday's Intraday Session
Carisma Therapeutics Shares Are Trading Lower After D. Boral Capital Cut Its Price Target on the Stock From $12 to $1.
Analysts Offer Insights on Healthcare Companies: Carisma Therapeutics (CARM), BioCardia (BCDA) and Guardian Pharmacy Services, Inc. Class A (GRDN)
Carisma Therapeutics Price Target Cut to $1.00/Share From $12.00 by D. Boral Capital
Express News | D. Boral Capital Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $1
Carisma Therapeutics Exploring Strategic Alternatives After Job Cuts
Express News | Carisma Therapeutics Inc: Has Paused All Research and Development Activities at This Time, Pending Outcome of Review
Express News | Carisma : May Engage External Advisors to Support Evaluation of Strategic Alternatives, Prepare for Potential Wind-Down of Operations, if Necessary
Carisma Therapeutics | 10-K: FY2024 Annual Report
Express News | Carisma Therapeutics Inc: Estimates That It Has Cash and Cash Equivalents Sufficient to Fund Its Operations Into Second Half of 2025
Express News | Carisma Therapeutics Inc: Has Reduced Its Workforce, Retaining Only Those Employees Deemed Essential to Pursue Strategic Alternatives
Express News | Carisma Therapeutics Inc: To Explore Strategic Alternatives to Advance Liver Fibrosis and Oncology Assets and Reduce Operational Cash Burn
Express News | Carisma Therapeutics Provides Corporate Updates
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025